Once daily dosing with neoral utilizing C2 monitoring in de novo liver transplant patients.

被引：0
|
作者：
Levy, GA [1 ]
Lilly, LB [1 ]
Girgrah, NT [1 ]
Cattral, MS [1 ]
Greig, PD [1 ]
Smith, R [1 ]
Grant, DR [1 ]
机构：
[1] Toronto Gen Hosp, Toronto, ON, Canada
来源：
LIVER TRANSPLANTATION | 2004年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
294
引用
收藏
页码：C74 / C74
页数：1
相关论文
共 50 条
  • [41] Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients
    Cole, E
    Naham, N
    Cardella, C
    Cattran, D
    Fenton, S
    Hamel, J
    O'Grady, C
    Smith, R
    TRANSPLANTATION, 2003, 75 (12) : 2086 - 2090
  • [42] Neoral (cyclosporine) C2 monitoring in renal transplant recipients:: A single-center experience in Asia
    Wong, HS
    Morad, Z
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (01) : 230 - 231
  • [43] Pitfall of C2 monitoring in renal transplant recipients - influence of meals and timing of neoral administration on therapeutic drug monitoring
    Ohtsuka, Satoki
    Uchida, Kazuharu
    Kobayashi, Takaaki
    Nakao, Akimasa
    TRANSPLANT INTERNATIONAL, 2007, 20 : 123 - 123
  • [44] PREDICTING BODY WEIGHT LOSS AFTER ONCE DAILY DOSING OF SEMAGLUTIDE IN OBESITY PATIENTS FROM ONCE WEEKLY DOSING DATA IN TYPE 2 DIABETIC PATIENTS.
    Zheng, S.
    Wang, J.
    Wang, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S95 - S95
  • [45] DELTA STUDY: DUTCH EVALUATION IN LIVER TRANSPLANTATION TO ASSESS THE EFFICACY OF CYCLOSPORIN A MICROEMULSION WITH C2 MONITORING VERSUS TACROLIMUS WITH TROUGH MONITORING IN DE NOVO TRANSPLANT RECIPIENTS
    Inderson, Akin
    van den Berg, Aad
    Metselaar, Herold
    Ringers, Jan
    Porte, Robert J.
    Kazemier, Geert
    van Hoek, Bart
    TRANSPLANT INTERNATIONAL, 2011, 24 : 201 - 201
  • [46] RATIONALE FOR NEORAL C0 AND C2 MONITORING IN INFANTS IN THE EARLY POST LIVER TRANSPLANTATION PERIOD
    Furlan, Valerie
    Lykavieris, Panayotis
    Maubert, Marie-Anne
    Habes, Dalila
    Debray, Dominique
    TRANSPLANT INTERNATIONAL, 2009, 22 : 339 - 339
  • [47] Therapeutic Drug Monitoring in De Novo Kidney Transplant Receiving the Modified-Release Once-Daily Tacrolimus
    Jelassi, M. L.
    Lefeuvre, S.
    Karras, A.
    Moulonguet, L.
    Billaud, E. M.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (02) : 491 - 494
  • [48] AM and PM C2 monitoring of cyclosporine in liver transplant recipients
    Baraldo, M
    Pavan, F
    Brollo, L
    Di Qual, E
    Franceschi, L
    Furlanut, M
    THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 508 - 508
  • [49] A Prospective, Multicenter Study of Once-Daily Extended-Release Tacrolimus in De Novo Liver Transplant Recipients
    Charco, R.
    Caralt, M.
    Llado, L.
    Valdivieso, A.
    Fabregat, J.
    Matarranz, A.
    Gonzalez-Pinto, I.
    Pardo, F.
    Fabrega, E.
    Bilbao, I.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (03) : 718 - 723
  • [50] A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients
    Shenoy, Surendra
    Hardinger, Karen L.
    Crippin, Jeffrey
    Korenblat, Kevin
    Lisker-Melman, Mauricio
    Lowell, Jeffrey A.
    Chapman, William
    LIVER TRANSPLANTATION, 2008, 14 (02) : 173 - 180
12345